Log In
Print
BCIQ
Print
Print this Print this
 

JHL1921

  Manage Alerts
Collapse Summary General Information
Company JHL Biotech Inc.
DescriptionBiosimilar
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today